Naoki Omachi

607 total citations
26 papers, 432 citations indexed

About

Naoki Omachi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Naoki Omachi has authored 26 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Genetics. Recurrent topics in Naoki Omachi's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (13 papers) and Vascular Anomalies and Treatments (7 papers). Naoki Omachi is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (13 papers) and Vascular Anomalies and Treatments (7 papers). Naoki Omachi collaborates with scholars based in Japan and Nepal. Naoki Omachi's co-authors include Shinji Atagi, Kyoichi Okishio, Akihiro Tamiya, Tomoya Kawaguchi, Naoko Takeuchi, Kazuhiro Asami, Hideo Ishikawa, Tomonori Hirashima, Tomohisa Okuma and Motohiro Tamiya and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Naoki Omachi

26 papers receiving 426 citations

Peers

Naoki Omachi

PRM

ONCOL

GENET

EPIDE

Olivia Wilkins United States

Angela Botticella France

Ronan Tanguy France

D. Paillotin France

Shireen Parsai United States

Jun Dang China

James Xu United States

I. Brisbane United Kingdom

Richard Harman New Zealand

Yasuhiro Hiyoshi Japan

Olivia Wilkins United States

Naoki Omachi

183 ×0.5

PRM

309 ×1.2

ONCOL

32 ×0.4

GENET

37 ×0.5

14 ×0.2

EPIDE

Citations per year, relative to Naoki Omachi Naoki Omachi (= 1×) peers Olivia Wilkins

Countries citing papers authored by Naoki Omachi

Since Specialization

Citations

This map shows the geographic impact of Naoki Omachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Omachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Omachi more than expected).

Fields of papers citing papers by Naoki Omachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Omachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Omachi. The network helps show where Naoki Omachi may publish in the future.

Co-authorship network of co-authors of Naoki Omachi

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Omachi. A scholar is included among the top collaborators of Naoki Omachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Omachi. Naoki Omachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishikawa, Hideo, et al.. (2023). A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion. 1(2). 28–41. 2 indexed citations

Nishihara, Takashi, et al.. (2022). Prevalence of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization. European Radiology. 33(6). 4198–4204. 7 indexed citations

Ishikawa, Hideo, Hiroyuki Ohbe, Naoki Omachi, Kojiro Morita, & Hideo Yasunaga. (2021). Spinal Cord Infarction after Bronchial Artery Embolization for Hemoptysis: A Nationwide Observational Study in Japan. Radiology. 298(3). 673–679. 28 indexed citations

Omachi, Naoki, Hideo Ishikawa, Masahiko Hara, et al.. (2021). The impact of bronchial artery embolisation on the quality of life of patients with haemoptysis: a prospective observational study. European Radiology. 31(7). 5351–5360. 9 indexed citations

Omachi, Naoki, et al.. (2021). Bronchial Artery Aneurysm: Prevalence, Clinical Characteristics, and Long-Term Prognosis Following Bronchial Artery Embolization. Journal of Vascular and Interventional Radiology. 33(2). 121–129. 4 indexed citations

Hara, Masahiko, et al.. (2018). Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study. European Radiology. 29(2). 707–715. 24 indexed citations

Taniguchi, Yoshihiko, N. Saijo, Akihiro Tamiya, et al.. (2017). The efficacy of a reduced dose (40mg) of osimertinib with T790M-positive advanced non-small-cell lung cancer. Annals of Oncology. 28. x130–x130. 6 indexed citations

Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2017). OA08.05 Efficacy and Cerebrospinal Fluid Concentration of Afatinib in NSCLC Patients with EGFR Mutation Developing Leptomeningeal Carcinomatosis. Journal of Thoracic Oncology. 12(1). S273–S273. 6 indexed citations

Tamiya, Motohiro, Akihiro Tamiya, Takayuki Shiroyama, et al.. (2017). Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations. Investigational New Drugs. 36(4). 608–614. 3 indexed citations

10.

Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2017). Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study. Anticancer Research. 37(8). 4177–4182. 70 indexed citations

11.

Naito, Yujiro, Akihiro Tamiya, Motohiro Tamiya, et al.. (2017). Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer. Medicine. 96(35). e7884–e7884. 14 indexed citations

12.

Morimoto, Masahiro, Kyoichi Okishio, Masanori Akira, et al.. (2016). Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer. Clinical Lung Cancer. 18(2). e117–e127. 4 indexed citations

13.

Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2016). Afatinib efficacy and cerebrospinal fluid concentration in NSCLC patients with EGFR mutation developing leptomeningeal carcinomatosis. Annals of Oncology. 27. vi428–vi428. 6 indexed citations

14.

Tamiya, Akihiro, Motohiro Tamiya, Takayuki Shiroyama, et al.. (2015). Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations. Medical Oncology. 32(3). 40–40. 15 indexed citations

15.

Asami, Kazuhiro, Masaaki Kawahara, Tomonori Hirashima, et al.. (2014). Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non‐squamous cell non‐small cell lung cancer in Japan. Thoracic Cancer. 5(4). 289–296. 2 indexed citations

16.

Omachi, Naoki, Shigeki Shimizu, Tomoya Kawaguchi, et al.. (2014). A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib. Journal of Thoracic Oncology. 9(6). e40–e42. 45 indexed citations

17.

Isa, Shun‐ichi, Satomi Yamamoto, Akihiro Tamiya, et al.. (2014). Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer. Oncology Letters. 9(2). 927–929. 7 indexed citations

18.

Omachi, Naoki, Motohiro Tamiya, Akihiro Tamiya, et al.. (2014). Preliminary analysis of the phase II study of pemetrexed plus carboplatin as first-line chemotherapy for elderly patients with advanced nonsquamous, non-small cell lung cancer.. Journal of Clinical Oncology. 32(15_suppl). e19162–e19162. 1 indexed citations

19.

Nishie, Kenichi, Tomoya Kawaguchi, Akihiro Tamiya, et al.. (2012). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations. Journal of Thoracic Oncology. 7(11). 1722–1727. 81 indexed citations

20.

Asami, Kazuhiro, Tomohisa Okuma, Tomonori Hirashima, et al.. (2012). Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations. Lung Cancer. 79(3). 276–282. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact